Radiotherapy, Breast neoplasms, Radiodermatitis, Women
Conditions
Interventions
The sample will be composed of 42 patients divided into three study groups by random allocation - randomization - (each group will consist of 14 patients).
Group A - experimental: 14 women with breas
use of soft and wide programs
protecting an irradiated area of ??irritants, avoiding the use of deodorants, perfumes and cosmetics
avoid depilation and, if necessary, use electric tricotomizer apparatus
keep a radiated skin dry and use soft battles
avoid swimming in lakes, swimming pools, sea and use of hot tubs and saunas
avoid the use of ribbons, adhesives and thermal compresses (cold or hot) over an irradiated area
avoid sun exposure in the irradiated area
avoid the use of topical prod
Drug
H01.603.600
Sponsors
Escola de Enfermagem da Universidade de São Paulo
Santa Casa de Misericórdia de Passos
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: be 18 years or older; and present the entire skin on the day radiotherapy begins.
Exclusion criteria
Exclusion criteria: previous radiotherapy in the same area; previus radical mastectomy; be pregnant; have a malignant fungating wound in the irradiated area; report history of adverse reaction to components of the cream formula; be on concomitant chemotherapy; use concomitant topical or systemic anti-inflammatory therapy; collagen diseases such as systemic lupus erythematosus and scleroderma; receive another type of intervention to prevent radiodermatitis, not included in the standard or experimental protocol; and refuse to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in the incidence of radiodermatitis during the entire radiotherapy treatment, verified in clinical reassessments that will be performed three times a week, from the first day of the session to the 14th day after the last session (two weeks after). Reduction in the intensity (degree) of radiodermatitis developed by the patients during the entire radiotherapy treatment, evaluated by the RTOG - Radiation Therapy Oncology Group, from 0 to 4; clinical reevaluations that will be performed three times a week, from the first day of the session to the 14th day after the last session (two weeks after). | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life at the beginning and at the end of radiotherapy, assessed by means of a quality of life questionnaire - EORTC-QLQ-30 (EORTC Quality of Life Questionnaire) and the quality of life assessment questionnaire for patients with breast cancer - EORTC-QLQ-BR23 (EORTC Quality of Life Questionnaire - Breast Cancer). Both questionnaires will be applied on the first day of radiotherapy session and after the end of radiotherapy treatment. | — |
Countries
Brazil
Contacts
Public ContactFernanda Schmidt
Escola de Enfermagem da Universidade de São Paulo
Outcome results
None listed